Figure 6
Drug discovery of PTPN2 in AML. (a) Drug screening in patients with high PTPN2 expression in CTRP and PRISM. (b) CMAP analysis between high and low PTPN2 expression groups.
Figure 6 | Scientific Reports
Drug discovery of PTPN2 in AML. (a) Drug screening in patients with high PTPN2 expression in CTRP and PRISM. (b) CMAP analysis between high and low PTPN2 expression groups.
